According to the World Health Organization, four cough syrups made in India are linked to 66 child deaths in the country.
There were deaths of children from injuries in the country.
The health body is looking into the matter with the firm.
Regulators have been told to stop selling the syrups.
The WHO's product alert has yet to be commented on by India's health ministry and drugs regulators.
The company has been contacted by the British Broadcasting Corporation.
According to Indian government sources, India's drug regulators launched an investigation after they were informed of the problem.
They said that the WHO was asked to share its report on the relation of death with medical products.
The WHO findings came after samples of each cough syrup were tested. The medicines were identified as Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip NCold Syrup.
According to the health body, the syrups contain unacceptable amounts of diethylene glycol and ethylene glycol, which can prove fatal when eaten.
According to the WHO, the products may have been distributed to other countries through informal markets.
All batches of these products should be considered unsafe until they can be analysed.
The company has only exported these cough syrups to The Gambia so far.
Most of the world's medicines are produced in India.
Much of the medical needs of African nations are met by the country, which is home to some of the fastest growing pharmaceutical companies.
Asia, Africa and Latin America are some of the countries in which the company exports its products.
In July, medical officers in The Gambia raised the alarm after a number of children were found to have seriousKidney problems.
According to the director of health services, Mustapha Bittaye, the number of deaths had gone down recently and that the country had banned the sale of the products.
He said that some of the syrups were still being sold in private clinics and hospitals.
All Rights Reserved © 2024
